Effective nanoprobes and contrast agents are urgently sought for earlystage cancer diagnosis. Upconversion nanoparticles (UCNPs) are considerable alternatives for bioimaging, cancer diagnosis, and therapy. Yb 3+ / Tm 3+ co-doping brings both emission and excitation wavelengths into the near-infrared (NIR) region, which is known as "optical transmission window" and ideally suitable for bioimaging. Here, NIR emission intensity is remarkably enhanced by 113 times with the increase of Yb 3+ concentration from 20% to 98% in polyethylene glycol (PEG) modifi ed NaYF 4 :Yb 3+ / Tm 3+ UCNPs. PEG-UCNPs-5 (98% Yb 3+ ) can act as excellent nanoprobes and contrast agents for trimodal upconversion (UC) optical/CT/T 2 -weighted magnetic resonance imaging (MRI). In addition, the enhanced detection of lung in vivo long-lasting tracking, as well as possible clearance mechanism and excretion routes of PEG-UCNPs-5 have been demonstrated. More signifi cantly, a small tumor down to 4 mm is detected in vivo via intravenous injection of these nanoprobes under both UC optical and T 2 -weighted MRI modalities. PEG-UCNPs-5 can emerge as bioprobes for multi-modal bioimaging, disease diagnosis, and therapy, especially the early-stage tumor diagnosis.